183 related articles for article (PubMed ID: 30382511)
1. Editors' Commentary for Special Issue: The 2017 CALDAR Summer Institute and International Conference Promoting Global Health-Precision Research in Substance Abuse, HIV, and Care.
Chang L; Li MD; Hser YI
J Neuroimmune Pharmacol; 2018 Dec; 13(4):427-429. PubMed ID: 30382511
[TBL] [Abstract][Full Text] [Related]
2. The 2017 CALDAR Summer Institute and International Conference Promoting Global Health-Precision Research in Substance Abuse, HIV, and Care.
Hser YI; Li MD; Grella C; Brecht L; Chen Z; Chang SL; Chang L; Normand J; Tai B
J Neuroimmune Pharmacol; 2017 Jun; 12(Suppl 2):79-80. PubMed ID: 28497234
[TBL] [Abstract][Full Text] [Related]
3. Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.
Li MD; Hser YI; Chen Z; Chang L
J Neuroimmune Pharmacol; 2016 Sep; 11(3):379-82. PubMed ID: 27484319
[TBL] [Abstract][Full Text] [Related]
4. Unraveling neuroHIV in the Presence of Substance Use Disorders.
Lin Y; He JJ; Sorensen R; Chang L
J Neuroimmune Pharmacol; 2020 Dec; 15(4):578-583. PubMed ID: 33215327
[TBL] [Abstract][Full Text] [Related]
5. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
6. Community Partnership in Precision Medicine: Themes from a Community Engagement Conference.
Jones L; Wells K; Lin HJ; Wang C; Alo AK; Williams P; Jones F; Dickson PI; Han S; Pardo D; Norris K; Jones A; Wright A; Young K; Rotter JI
Ethn Dis; 2018; 28(Suppl 2):503-510. PubMed ID: 30202204
[TBL] [Abstract][Full Text] [Related]
7. The 20th scientific conference of the Society on NeuroImmune Pharmacology.
Fox HS
J Neuroimmune Pharmacol; 2014 Mar; 9(1):1-2. PubMed ID: 24573530
[TBL] [Abstract][Full Text] [Related]
8. Issues of social impact and response. Amsterdam report.
Bryce J
AIDS Soc; 1992; 3(4):5, 8. PubMed ID: 12317711
[TBL] [Abstract][Full Text] [Related]
9. Use of mental health and substance abuse treatment services among adults with HIV in the United States.
Burnam MA; Bing EG; Morton SC; Sherbourne C; Fleishman JA; London AS; Vitiello B; Stein M; Bozzette SA; Shapiro MF
Arch Gen Psychiatry; 2001 Aug; 58(8):729-36. PubMed ID: 11483138
[TBL] [Abstract][Full Text] [Related]
10. Testing the effectiveness of a motivational interviewing-based brief intervention for substance use as an adjunct to usual care in community-based AIDS service organizations: study protocol for a multisite randomized controlled trial.
Garner BR; Gotham HJ; Tueller SJ; Ball EL; Kaiser D; Stilen P; Speck K; Vandersloot D; Rieckmann TR; Chaple M; Martin EG; Martino S
Addict Sci Clin Pract; 2017 Nov; 12(1):31. PubMed ID: 29149914
[TBL] [Abstract][Full Text] [Related]
11. Advancing American Indian and Alaska Native substance abuse research: current science and future directions.
Etz KE; Arroyo JA; Crump AD; Rosa CL; Scott MS
Am J Drug Alcohol Abuse; 2012 Sep; 38(5):372-5. PubMed ID: 22931068
[TBL] [Abstract][Full Text] [Related]
12. Adding Resistance Training to the Standard of Care for Inpatient Substance Abuse Treatment in Men With Human Immunodeficiency Virus Improves Skeletal Muscle Health Without Altering Cytokine Concentrations.
Vingren JL; Curtis JH; Levitt DE; Duplanty AA; Lee EC; McFarlin BK; Hill DW
J Strength Cond Res; 2018 Jan; 32(1):76-82. PubMed ID: 29257793
[TBL] [Abstract][Full Text] [Related]
13. Introduction to the Special Issue on the Studies on the Implementation of Integrated Models of Alcohol, Tobacco, and/or Drug Use Interventions and Medical Care.
Hunter SB; Schwartz RP; Friedmann PD
J Subst Abuse Treat; 2016 Jan; 60():1-5. PubMed ID: 26549295
[TBL] [Abstract][Full Text] [Related]
14. Health services research: drug use and human immunodeficiency virus in the United States.
Flanzer J
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S439-44. PubMed ID: 14648461
[TBL] [Abstract][Full Text] [Related]
15. Editors' introduction: Identifying and assessing promising practices for criminal justice clients--California Substance Abuse Research Consortium (SARC) meetings, 2010.
Urada D; Rutkowski BA; Rawson RA; Freese TE
J Psychoactive Drugs; 2011 Sep; Suppl 7():3-9. PubMed ID: 22185034
[TBL] [Abstract][Full Text] [Related]
16. The Santorini Conferences continue.
Siest S
Drug Metab Pers Ther; 2016 Dec; 31(4):179. PubMed ID: 27889703
[No Abstract] [Full Text] [Related]
17. Triple diagnosis: dual diagnosis and HIV disease, Part 1.
Douaihy AB; Jou RJ; Gorske T; Salloum IM
AIDS Read; 2003 Jul; 13(7):331-2, 339-41. PubMed ID: 12889451
[TBL] [Abstract][Full Text] [Related]
18. Substance abuse and HIV infection.
Francis H
Top HIV Med; 2003; 11(1):20-4. PubMed ID: 12717047
[TBL] [Abstract][Full Text] [Related]
19. Health care services for HIV-positive substance abusers in a rural setting: an innovative program.
Wood SA
Soc Work Health Care; 2008; 47(2):108-21. PubMed ID: 18956503
[TBL] [Abstract][Full Text] [Related]
20. Drug abuse health services funding available.
AIDS Read; 2001 Aug; 11(8):398. PubMed ID: 11570263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
